drugset / Trial / NCT06315478
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians
RandomizedSequentialOpen-labelTreatment
Summary
Our study aimed to investigate the efficacy and safety of hybrid regimen as a first line therapy for H. pylori eradication compared to triple and quadruple regimens in attempt to overcome antibiotic resistance
Timeline
- Start
- 2021-02-01
- Primary completion
- 2021-03-16
- Completion
- 2021-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 500 mg | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Comparator | Metronidazole | Small molecule | 500 mg | — |
| Comparator | Omeprazole | Other / unclassified | 20 mg | Oral |